Li Guoqing, Zhou Xiaoling, Li Wenhan, Wu Qiulei, Liu Tong, Huang Lin, Liu Xiaoli, Zhao Jing, Xu Xiaohan, Xu Linjuan, Wang Zehua, Gong Lanqing, Cai Liqiong, Cai Jing
Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
J Nanobiotechnology. 2025 Jul 26;23(1):540. doi: 10.1186/s12951-025-03612-7.
Ovarian cancer exhibits striking metastatic tropism for the omentum, where lipid-laden macrophages are key mediators that fuel disease progression. However, the mechanisms governing their formation and pro-metastatic functions remain poorly understood. As extracellular vesicles (EVs) have as critical regulators of tumor-stroma crosstalk in metastatic niches, we sought to define how ovarian cancer-derived EVs orchestrate macrophages and adipocytes, and their impact on omental metastasis, aiming to explore potential therapeutic interventions.
Single-cell transcriptomics of ovarian cancer revealed a distinct lipid-laden macrophage population in omentum, whose abundance correlated with metastatic burden and poor survival. Proteomics revealed that EVs from highly metastatic ovarian cancer cells were enriched in lipid metabolism regulators. In vivo experiments demonstrated that these tumor-derived vesicles mediated macrophage reprogramming, driving the acquisition of a pro-metastatic phenotype. Quantitative lipidomic profiling and lipid staining approaches confirmed the progressive lipid-laden in EV-treated macrophages. Using a patient-derived omentum-macrophage co-culture system, we demonstrated that tumor-derived EVs stimulate lipid release from omental adipocytes, which macrophages subsequently internalize through CD36-dependent uptake to drive lipid accumulation. This metabolic reprogramming culminated in cellular senescence, as evidenced by classical biomarkers including SA-β-galactosidase activity, elevated p16-INK4A and p53 levels, and the development of a matrix metalloproteinase-enriched senescence-associated secretory phenotype. Immunohistochemistry of clinical specimens demonstrated overexpression of CD36 correlated with omental metastasis and poor survival in ovarian cancer. In vivo experiments demonstrated that CD36 inhibition and senolytic therapy attenuated omental metastasis.
This study unveils an EV-driven mechanism of adipose tropism in ovarian cancer metastasis, where EVs promote the formation of senescent lipid-laden macrophages via CD36-mediated lipid uptake, remodeling the metastatic niche. Targeting CD36 and senescent cells offers a promising therapeutic strategy against omental metastasis.
卵巢癌对大网膜表现出显著的转移嗜性,其中富含脂质的巨噬细胞是推动疾病进展的关键介质。然而,控制它们形成和促转移功能的机制仍知之甚少。由于细胞外囊泡(EVs)是转移微环境中肿瘤-基质相互作用的关键调节因子,我们试图确定卵巢癌来源的EVs如何协调巨噬细胞和脂肪细胞,以及它们对大网膜转移的影响,旨在探索潜在的治疗干预措施。
卵巢癌的单细胞转录组学揭示了大网膜中一个独特的富含脂质的巨噬细胞群体,其丰度与转移负担和不良生存率相关。蛋白质组学显示,高转移性卵巢癌细胞来源的EVs富含脂质代谢调节因子。体内实验表明,这些肿瘤来源的囊泡介导巨噬细胞重编程,促使其获得促转移表型。定量脂质组学分析和脂质染色方法证实了经EVs处理的巨噬细胞中脂质逐渐积累。使用患者来源的大网膜-巨噬细胞共培养系统,我们证明肿瘤来源的EVs刺激大网膜脂肪细胞释放脂质,巨噬细胞随后通过CD36依赖性摄取将其内化以驱动脂质积累。这种代谢重编程最终导致细胞衰老,包括SA-β-半乳糖苷酶活性、p16-INK4A和p53水平升高以及富含基质金属蛋白酶的衰老相关分泌表型的出现等经典生物标志物可证明这一点。临床标本的免疫组织化学显示,CD36的过表达与卵巢癌的大网膜转移和不良生存率相关。体内实验表明,CD36抑制和衰老细胞溶解疗法可减轻大网膜转移。
本研究揭示了卵巢癌转移中一种由EVs驱动的脂肪嗜性机制,其中EVs通过CD36介导的脂质摄取促进衰老的富含脂质的巨噬细胞形成,重塑转移微环境。靶向CD36和衰老细胞为对抗大网膜转移提供了一种有前景的治疗策略。